{"database": "lobbying", "table": "lobbying_activities", "rows": [[3242151, "7d3b1d21-97aa-4db0-bccc-842b46db6ba4", "Q3", "ELI LILLY AND COMPANY", 13392, "ELI LILLY AND COMPANY", 2024, "third_quarter", "CSP", "Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality", "Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", null, 1795000, 0, 0, "2024-10-17T10:18:05-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3242151"], "units": {}, "query_ms": 13.713062042370439, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}